WRONG! Anavex owns the patents, not Missling. Missling is just the author or a co-author. A strong patent portfolio is a necessity in biotech... technology in general.
Missing, there is an assignment of the patent rights to Anavex by any of the author and/or co-authors. It is how it has worked in corporations for decades.
But nice try at today's FUD 💩 ... you are learning, but not very well.
News 
Market Data 
Discover 
